PTGX

Protagonist Therapeutics, Inc. (PTGX)

Last Price$37.2(1.6%)
Market Cap$2,297.8M
Intrinsic value score
7/10
Great
Intrinsic value
$19.6
DCF value - N/A Relative value - $19.6
Overvalued
47.3%
LTM P/E
13.4x
Peer set median (33.0x)
Discount rate
11.4%

PTGX Intrinsic value

Crunching data... Almost there!

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

PTGX Historical Intrinsic Value

Crunching data... Almost there!

PTGX vs Peer Set: Intrinsic Value Comparison

Crunching data... Almost there!

Explore more intrinsic value tools hub for PTGX

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

What is Protagonist Therapeutics, Inc. intrinsic value?

As of Feb 03, 2025, Protagonist Therapeutics, Inc. Intrinsic Value is $19.6. This suggests it may be overvalued by 47.3% compared to its current price of around $37.2.

What is Protagonist Therapeutics, Inc. DCF (discounted cash flow) valuation?

As of Feb 03, 2025, Protagonist Therapeutics, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $37.2, using a discount rate of 11.4% and terminal growth rate of 3.0%.

Is Protagonist Therapeutics, Inc. overvalued or undervalued?

Protagonist Therapeutics, Inc. is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $19.6, compared to a market price of around $37.2. This suggests a potential overvaluation of 47.3%.